Clinical Trial Update: A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial of aripiprazole in children and adolescents with Asperger's Disorder and pervasive developmental disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Disorder
• Pervasive Developmental Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Asperger's Disorder, Pervasive Developmental Disorder | Phase 2 | Status: COMPLETED